Skip to content

To explore the effect of thoracic paravertebral analgesia with different intervals on thoracic postoperative recovery

To explore the effects of different interstitial thoracic paravertebral analgesia on recovery after thoracoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110504
Enrollment
Unknown
Registered
2025-10-14
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain after thoracic surgery

Interventions

Group A:The TPVB block space is the thoracic paravertebral space corresponding to the surgical incision and the adjacent upper space
Group:The TPVB block space is the thoracic paravertebral space corresponding to the surgical incision and the adjacent downward space
Group C:The TPVB block space is the upper and lower space adjacent to the thoracic paravertebral space corresponding to the surgical incision, and the space where the surgical incision sits is not inj

Sponsors

Beijing Chest Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. ASA classification I-III, age 18-70, gender is not limited; 2. Patients undergoing single-port thoracoscopic surgery, with lung wedge, lung segment and lobectomy;

Exclusion criteria

Exclusion criteria: 1. Patients who are not treated with a multimodal analgesic regimen (thoracic paravertebral block, intravenous analgesic pump); 2. Patients with contraindications to paravertebral block, such as a history of thoracic spine injury, anatomical variation of thoracic vertebral segments, infectious diseases in the skin tissue at the injection site, and abnormal coagulation function; 3. Patients with persistent chronic pain before surgery; 4. Patients with opioid and alcohol dependence; 5. Patients with previous allergy to local anesthetics; 6. morbidly obese patients (BMI>40 kg/m^2); 7. Patients with severe cardiovascular and cerebrovascular diseases; 8. Patients who are unable to express themselves verbally or do not respond to pain scores; 9. Pregnant or lactating females, those who have a birth plan within half a year, and who are unwilling or unable to take effective contraceptive measures 10. Patients who voluntarily request to withdraw from the study;

Design outcomes

Primary

MeasureTime frame
AUC area of cough NRS score 0-48 h postoperatively;

Secondary

MeasureTime frame
Postoperative 4, 24, and 48h NRS scores;Opioid consumption at the end of the operation, 24 hours, and 48 hours after surgery;Patient's Ramsay score in PACU;QoR-15 score at 48h postoperatively;The number of effective compressions of the analgesic pump and the postoperative analgesic remediation;Perioperative blood pressure, heart rate, blood oxygen;Duration of indwelling drain and length of hospital stay;Postoperative complications;Intraoperative changes in blood glucose;Postoperative CRP content;

Countries

China

Contacts

Public ContactLiu Tao

Beijing Chest Hospital Affiliated to Capital Medical University

mz89509089@sina.com+86 10 8950 9089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026